Cargando…
Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline
BACKGROUND: Neoadjuvant chemotherapy (NAC) is one of the standard care regimens for patients with resectable early-stage breast cancer. It would be advantageous to determine the chemosensitivity of tumors before initiating NAC. One of the parameters potentially compromising such chemosensitivity wou...
Autores principales: | Aomatsu, Naoki, Yashiro, Masakazu, Kashiwagi, Shinichiro, Kawajiri, Hidemi, Takashima, Tsutomu, Ohsawa, Masahiko, Wakasa, Kenichi, Hirakawa, Kosei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058694/ https://www.ncbi.nlm.nih.gov/pubmed/24893880 http://dx.doi.org/10.1186/1471-2407-14-400 |
Ejemplares similares
-
CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Aomatsu, Naoki, et al.
Publicado: (2012) -
Reactive lymphoid hyperplasia of the thyroid followed by systemic autoimmune diseases: a case report
por: Onoda, Naoyoshi, et al.
Publicado: (2014) -
Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer
por: KAWAJIRI, HIDEMI, et al.
Publicado: (2014) -
Mammary phyllodes tumor with six episodes of a relapse: a case report
por: Iimori, Nozomi, et al.
Publicado: (2017) -
Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67
por: Kashiwagi, Shinichiro, et al.
Publicado: (2011)